EORTC Gynecological Cancer Group Spring Meeting 30-31 March 2023
This two days Conference will provide an opportunity for EORTC members to highlight their accomplishments, identify gaps, and generate new ideas for implementing future practice-changing clinical trials in gynecological cancers.
Three outstanding keynote speakers will discuss the challenges and opportunities for immunotherapy and PARP inhibitors in gynecological cancers:
- Prof. José Conejo Garcia, Duke University, USA: “Novel interventions to render CAR T cells finally effective against gynecologic tumors”.
- Prof. George Coukos, Lausanne University Hospital, CH: “Mobilizing immunity against HGSOC (and why it has not worked so far)”.
- Prof. Inthidar Labidi-Galy, University of Geneva, CH: “Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis”.
More information and free registration are available at firstname.lastname@example.org
Conference chairman: Dr. Fernanda Herrera - CHUV-University of Lausanne
EORTC Chairman Gynecology Cancer Group